Throughout the year, the AHA comments on a vast number of proposed and interim final rules put forth by the federal regulatory agencies. In addition, AHA communicates with federal legislators to convey the hospital field's position on potential legislative changes that would impact patients and patient care. Below are the most recent letters from the AHA to these bodies.


Sep 26, 2022
A coalition of organizations, including the AHA, urge the Department of Health and Human Services to consider postponing for one year the Oct. 6 deadline for health care providers to begin sharing all electronic protected health information in a designated record set, as defined under HIPAA, to ensure they understand the requirements and have the technology to support them.
Sep 26, 2022
AHA thanks Reps. Jason Crow, D-Colo., and Brian Fitzpatrick, R-Pa., for introducing a House companion to the Healthcare Cybersecurity Act (S.3904/H.R.8806),
Sep 13, 2022
AHA comments on the CMS' hospital outpatient prospective payment system and ambulatory surgical center payment system proposed rule for calendar year (CY) 2023.
Sep 8, 2022
Organizations that represent laboratories, health care providers, laboratory professionals, and diagnostic manufacturers urge Congress to take action to protect patient access to clinical laboratory services.
Sep 6, 2022
AHA comments on the CMS’ Physician Fee Schedule Proposed Rule for calendar year 2023.
Aug 31, 2022
AHA comments in response to the Centers for Medicare & Medicaid Services’ Request for Information regarding the Medicare Advantage program.
Aug 26, 2022
AHA voices support for the Assistance for Rural Community Hospitals (ARCH) Act.
Aug 26, 2022
AHA comments on the Centers for Medicare & Medicaid Services’ (CMS) proposed conditions of participation (CoPs) for rural emergency hospitals (REHs) and CAHs.
Aug 26, 2022
AHA urges the Bureau of Land Management to take steps to protect Americans’ health prior to executing the final sale of the Federal Helium Reserve near Amarillo, Texas.
Aug 23, 2022
The AHA letter to the Centers for Medicare & Medicaid Services, cautioning against softening standards designed to maintain the safety and quality of laboratory testing in the U.S., including those regulating the professionals who staff the nation’s Clinical Laboratory Improvement Amendments-certified labs.